FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#39 | |||
|
||||
Senior Member
|
It seems Biogen Idec has decided to resume posting monthly reports on Tysabri-related PML cases, at least according to this in the Irish Examiner, January 8:
http://www.irishexaminer.com/busines...#ixzz0cGKdOR4q Supposedly there will be a December report some time this month.
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis, osteopenia. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, 12/16/20 - 3/16/24 |
|||
![]() |
![]() |
"Thanks for this!" says: |
|
|
![]() |
||||
Thread | Forum | |||
Can I be allowed to complain? | Multiple Sclerosis | |||
FDA warns Biogen about Tysabri advertising gaps | Multiple Sclerosis | |||
Biogen Reveals Another Tysabri PML Case | Multiple Sclerosis | |||
Biogen CEO Comments on Tysabri | Multiple Sclerosis |